BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26035378)

  • 21. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.
    Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI
    Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice.
    Woo LL; Egner PA; Belanger CL; Wattanawaraporn R; Trudel LJ; Croy RG; Groopman JD; Essigmann JM; Wogan GN; Bouhenguel JT
    Toxicol Sci; 2011 Jul; 122(1):38-44. PubMed ID: 21507988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mouse models to study the interaction of risk factors for human liver cancer.
    Sell S
    Cancer Res; 2003 Nov; 63(22):7553-62. PubMed ID: 14633666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
    Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
    J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression.
    Mello T; Materozzi M; Zanieri F; Simeone I; Ceni E; Bereshchenko O; Polvani S; Tarocchi M; Marroncini G; Nerlov C; Guasti D; Bani D; Pinzani M; Galli A
    Int J Cancer; 2020 Jun; 146(12):3410-3422. PubMed ID: 31721195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effect of hepatitis B virus and aflatoxin B1 in hepatocarcinogenesis in tree shrews.
    Li Y; Su JJ; Qin LL; Yang C; Ban KC; Yan RQ
    Ann Acad Med Singap; 1999 Jan; 28(1):67-71. PubMed ID: 10374028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors.
    Huang MN; Yu W; Teoh WW; Ardin M; Jusakul A; Ng AWT; Boot A; Abedi-Ardekani B; Villar S; Myint SS; Othman R; Poon SL; Heguy A; Olivier M; Hollstein M; Tan P; Teh BT; Sabapathy K; Zavadil J; Rozen SG
    Genome Res; 2017 Sep; 27(9):1475-1486. PubMed ID: 28739859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of a hepatitis B virus pre-S2 deletion mutant in the liver results in hepatomegaly and hepatocellular carcinoma in mice.
    Teng YC; Neo JC; Wu JC; Chen YF; Kao CH; Tsai TF
    J Pathol; 2017 Mar; 241(4):463-474. PubMed ID: 27868197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minisatellite rearrangements are increased in liver tumours induced by transplacental aflatoxin B1 treatment of hepatitis B virus transgenic mice, but not in spontaneously arising tumours.
    Kaplanski C; Chisari FV; Wild CP
    Carcinogenesis; 1997 Apr; 18(4):633-9. PubMed ID: 9111192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
    Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
    J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
    Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
    J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
    Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
    Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice.
    Kuo MT; Zhao JY; Teeter LD; Ikeguchi M; Chisari FV
    Cell Growth Differ; 1992 Aug; 3(8):531-40. PubMed ID: 1356418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus X antigen and aflatoxin B1 synergistically cause hepatitis, steatosis and liver hyperplasia in transgenic zebrafish.
    Lu JW; Yang WY; Lin YM; Jin SL; Yuh CH
    Acta Histochem; 2013 Sep; 115(7):728-39. PubMed ID: 23499292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression analysis in HBV transgenic mouse liver: a model to study early events related to hepatocarcinogenesis.
    Barone M; Spano D; D'Apolito M; Centra M; Lasalandra C; Capasso M; Di Leo A; Volinia S; Arcelli D; Rosso N; Francavilla A; Tiribelli C; Iolascon A
    Mol Med; 2006; 12(4-6):115-23. PubMed ID: 16953557
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Kastenhuber ER; Lalazar G; Houlihan SL; Tschaharganeh DF; Baslan T; Chen CC; Requena D; Tian S; Bosbach B; Wilkinson JE; Simon SM; Lowe SW
    Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13076-13084. PubMed ID: 29162699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus-associated hepatocellular carcinoma.
    Melis M; Diaz G; Kleiner DE; Zamboni F; Kabat J; Lai J; Mogavero G; Tice A; Engle RE; Becker S; Brown CR; Hanson JC; Rodriguez-Canales J; Emmert-Buck M; Govindarajan S; Kew M; Farci P
    J Transl Med; 2014 Aug; 12():230. PubMed ID: 25141867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.